clinical trial · NCT02220907
Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
Type 2 Diabetes MellitusTeneligliptin/Canagliflozin
brief summary
The purpose of this study is to evaluate the safety and efficacy of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 52 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequate glycemic control.
started
Aug 1, 2014
primary completion
Feb 1, 2016
completion
Feb 1, 2016
last updated
Jan 7, 2026
official title
Long-term Administration Study of MT-2412 in Patients With Type 2 Diabetes Mellitus
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol